Sarilumab for the Treatment of Moderate-to-Severe Rheumatoid Arthritis: Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled, International Study
Author(s):
Genovese, M.C.; Kivitz, A.J.; Campos, J.A.S.; Rell-Bakalarska, M.; Fleischmann, R.M.; Jasson, M.; Radin, A.R.; Huang, X.H.; Huizinga, T.W.J. (0000-0001-7033-7520)
Published
2011
Publication type
Article / Letter to editor
Date issued
2011-12-31
Language
English
Is part of
Arthritis and Rheumatism (2011), Vol. 63, no. 12, p. 4041-4042